参考文献/References:
[1] Moreno-Domínguez A,Colinas O,Smani T,et al. Acute oxygen sensing by vascular smooth muscle cells[J]. Front physiol,2023,14:1142354.
[2] Rani S,Roy S,Singh M,et al. Regulation of transactivation at C-TAD domain of HIF-1α by factor-inhibiting HIF-1α (FIH-1):a potential target for therapeutic intervention in cancer[J]. Oxid Med Cell Longev,2022,2022:2407223.
[3] Georgy M,Salhiyyah K,Yacoub MH,et al. Role of hypoxia inducible factor HIF-1 α in heart valves[J]. Glob Cardiol Sci Pract,2023,2023(2):e202309.
[4] Thompson AAR,Lawrie A. Targeting vascular remodeling to treat pulmonary arterial hypertension[J]. Trends Mol Med,2017,23(1):31-45.
[5] Taylor CT,Scholz CC. The effect of HIF on metabolism and immunity[J]. Nat Rev Nephrol,2022,18(9):573-587.
[6] 杨雪，杨勇. 代谢重编程对巨噬细胞的可塑性和功能的影响[J]. 药学研究,2019,38(8):481-485.
[7] Zeidan EM,Hossain MA,El-Daly M,et al. Mitochondrial regulation of the hypoxia-inducible factor in the development of pulmonary hypertension[J]. J Clin Med,2022,11(17):5219.
[8] Canton M,Sánchez-Rodríguez R,Spera I,et al. Reactive oxygen species in macrophages:sources and targets[J]. Front Immunol,2021,12:734229.
[9] Chen J,Zhang M,Liu Y,et al. Histone lactylation driven by mROS-mediated glycolytic shift promotes hypoxic pulmonary hypertension[J]. J Mol Cell Biol,2023,14(12):mjac073.
[10] Kao TW,Bai GH,Wang TL,et al. Novel cancer treatment paradigm targeting hypoxia-induced factor in?conjunction with current therapies to overcome resistance[J]. J Exp Clin Cancer Res,2023,42(1):171.
[11] Riou M,Enache I,Sauer F,et al. Targeting mitochondrial metabolic dysfunction in pulmonary hypertension:toward new therapeutic approaches?[J]. Int J Mol Sci,2023,24(11):9572.
[12] Thenappan T,Ormiston ML,Ryan JJ,et al. Pulmonary arterial hypertension:pathogenesis and clinical management[J]. BMJ,2018,360:j5492.
[13] Kassa B,Kumar R,Mickael C,et al. Endothelial cell PHD2-HIF1α-PFKFB3 contributes to right ventricle vascular adaptation in pulmonary hypertension[J]. Am J Physiol Lung Cell Mol Physiol,2021,321(4):L675-L685.
[14] Cao Y,Zhang X,Wang L,et al. PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension[J]. Proc Natl Acad Sci U S A,2019,116(27):13394-13403.
[15] Jaworska M,Szczud?o J,Pietrzyk A,et al. The Warburg effect:a score for many instruments in the concert of cancer and cancer niche cells[J]. Pharmacol Rep,2023,75(4):876-890.
[16] Xiao Y,Peng H,Hong C,et al. PDGF promotes the Warburg effect in pulmonary arterial smooth muscle cells via activation of the PI3K/AKT/mTOR/HIF-1α signaling pathway[J]. Cell Physiol Biochem,2017,42(4):1603-1613.
[17] Thomas LW,Ashcroft M. Exploring the molecular interface between hypoxia-inducible factor signalling and mitochondria[J]. Cell Mol Life Sci,2019,76(9):1759-1777.
[18] Breault NM,Wu D,Dasgupta A,et al. Acquired disorders of mitochondrial metabolism and dynamics in pulmonary arterial hypertension[J]. Front Cell Dev Biol,2023,11:1105565.
[19] Whitman E,Pisarcik S,Luke T,et al. Endothelin-1 mediates hypoxia-induced inhibition of voltage-gated K+ channel expression in pulmonary arterial myocytes[J]. Am J Physiol Lung Cell Mol Physiol,2008,294(2):L309- L318.
[20] He Y,Fang X,Shi J,et al. Apigenin attenuates pulmonary hypertension by inducing mitochondria-dependent apoptosis of PASMCs via inhibiting the hypoxia inducible factor 1alpha-KV1.5 channel pathway[J]. Chem Biol Interact,2020,317:108942.
[21] Masson B,Montani D,Humbert M,et al. Role of store-operated Ca2+ entry in the pulmonary vascular remodeling occurring in pulmonary arterial hypertensio n[J]. Biomolecules,2021,11(12):1781.
[22] Masson B,Saint-Martin Willer A,Dutheil M,et al. Contribution of TRPC channels in human and experimental pulmonary arterial hypertension[J]. Am J Physiol Lung Cell Mol Physiol,2023,325(2):L246-L261.
[23] Jain PP,Lai N,Xiong M,et al. TRPC6,a therapeutic target for pulmonary hypertension[J]. Am J Physiol Lung Cell Mol Physiol,2021,321(6):L1161-L1182.
[24] Wang J,Fu X,Yang K,et al. Hypoxia inducible factor-1-dependent up-regulation of BMP4 mediates hypoxia-induced increase of TRPC expression in PASMCs[J]. Cardiovasc Res,2015,107(1):108-118.
[25] Chai T,Qiu C,Xian Z,et al. A narrative review of research advances in hypoxic pulmonary hypertension[J]. Ann Transl Med,2022,10(4):230.
[26] Maron BA,Abman SH,Elliott CG,et al. Pulmonary arterial hypertension:diagnosis,treatment,and novel advances[J]. Am J Respir Crit Care Med,2021,203(12):1472-1487.
[27] Liu R,Yuan T,Wang R,et al. Insights into endothelin receptors in pulmonary hypertension[J]. Int J Mol Sci,2023,24(12):10206.
[28] Pisarcik S,Maylor J,Lu W,et al. Activation of hypoxia-inducible factor-1 in pulmonary arterial smooth muscle cells by endothelin-1[J]. Am J Physiol Lung Cell Mol Physiol,2013,304(8):L549-L561.
[29] Pullamsetti SS,Mamazhakypov A,Weissmann N,et al. Hypoxia-inducible factor signaling in pulmonary hypertension[J]. J Clin Invest,2020,130(11):5638-5651.
[30] 刘川川，马兰，格日力. HIF-1调控低氧性肺动脉高压[J]. 生理科学进展,2018,49(6):423-427.
[31] Li B,Zhu Y,Sun Q,et al. Reversal of the Warburg effect with DCA in PDGF?treated human PASMC is potentiated by pyruvate dehydrogenase kinase?1 inhibition mediated through blocking Akt/GSK?3β signalling [J]. Int J Mol Med,2018,42(3):1391-1400.
[32] Wang XY,Mo D,Tian W,et al. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels[J]. Toxicol Appl Pharmacol,2019,369:60-72.
[33] Sun XZ,Li SY,Tian XY,et al. Effect of Rho kinase inhibitor fasudil on the expression ET-1 and NO in rats with hypoxic pulmonary hypertension[J]. Clin Hemorheol Microcirc,2019,71(1):3-8.
[34] Jiang Y,Zhou Y,Peng G,et al. Topotecan prevents hypoxia-induced pulmonary arterial hypertension and inhibits hypoxia-inducible factor-1α and TRPC channels[J]. Int J Biochem Cell Biol,2018,104:161-170.
[35] Dai Y,Chen X,Song X,et al. Immunotherapy of endothelin-1 receptor type A for pulmonary arterial hypertension[J]. J Am Coll Cardiol,2019,73(20):2567-2580.
[36] Cullivan S,Higgins M,Gaine S. Diagnosis and management of pulmonary arterial hypertension[J]. Breathe (Sheff),2022,18(4):220168.